Clovis Oncology, Inc. (CLVS): Price and Financial Metrics
Today's Latest Price: $5.88 USD
Sep 25 4:00pm Add CLVS to Watchlist Sign Up
Buy & Hold Grade
Peer Grade Industry Rank
CLVS Stock Summary Clovis Oncology Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 4.38% of US listed stocks. CLVS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 2.81% of US stocks. Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for CLVS comes in at -45.03% -- higher than that of just 9.7% of stocks in our set. Stocks with similar financial metrics, market capitalization, and price volatility to Clovis Oncology Inc are CYTK, NVCN, RMBS, CLSN, and BCYC. Visit CLVS's SEC page to see the company's official filings. To visit the company's web site, go to www.clovisoncology.com.
CLVS Price/Volume Stats
Clovis Oncology, Inc. (CLVS) Company Bio
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. The company was founded in 2009 and is based in Boulder, Colorado.
CLVS Latest News Stream
All News Types
Commentary Corp. News Cramer Debt Offering Downgrade Earnings Hedge Fund New Coverage (Bearish) New Coverage (Bullish) New Coverage (Neutral) Options Product News PT Lowered PT Raised PT Set (Bullish) Rating Reiterated (Bearish) Rating Reiterated (Bullish) Rating Reiterated (Neutral) Resumes Coverage (Bullish) Rumor Stock Offering Upgrade
Loading, please wait...
Latest CLVS News From Around the Web
Below are the latest news stories about Clovis Oncology Inc that investors may wish to consider to help them evaluate CLVS as an investment opportunity.
The following slide deck was published by Clovis Oncology, Inc. in conjunction with this event....
BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology Announces Oral Plenary Session Presentation at International Gynecologic Cancer Society (IGCS) Digital Annual Global Meeting
BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology to Highlight Data for its Three Portfolio Compounds at the ESMO Virtual Congress 2020
Clovis Oncology to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Investors need to pay close attention to Clovis Oncology (CLVS) stock based on the movements in the options market lately.
Read More 'CLVS' Stories Here
CLVS Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.7764 seconds.